- £4.35bn
- £5.12bn
- $2.88bn
- 74
- 49
- 70
- 73
REG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Block listing Interim Review
AnnouncementREG - Hikma Pharmaceutical - Hikma acquires Custopharm
AnnouncementREG - Stock Exch Notice - Admission to Trading - 24/09/2021
AnnouncementREG - Hikma Pharmaceutical - Additional Listing
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementRCS - Hikma Pharmaceutical - Bio-Thera and Hikma announce exclusive agreement
AnnouncementREG - Hikma Pharmaceutical - Half-year Report
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Notice of Results
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementRCS - Hikma Pharmaceutical - Hikma announces US FDA approval of KLOXXADO
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
Announcement